These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 33361717)

  • 21. FISHing Tips: What Every Clinician Should Know About 1p19q Analysis in Gliomas Using Fluorescence in situ Hybridisation.
    Pinkham MB; Telford N; Whitfield GA; Colaco RJ; O'Neill F; McBain CA
    Clin Oncol (R Coll Radiol); 2015 Aug; 27(8):445-53. PubMed ID: 25971646
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Not all 1p/19q non-codeleted oligodendroglial tumors are astrocytic.
    Li YX; Shi Z; Aibaidula A; Chen H; Tang Q; Li KK; Chung NY; Chan DT; Poon WS; Mao Y; Wu J; Zhou L; Chan AK; Ng HK
    Oncotarget; 2016 Oct; 7(40):64615-64630. PubMed ID: 27556304
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinicopathologic features of pediatric oligodendrogliomas: a series of 50 patients.
    Rodriguez FJ; Tihan T; Lin D; McDonald W; Nigro J; Feuerstein B; Jackson S; Cohen K; Burger PC
    Am J Surg Pathol; 2014 Aug; 38(8):1058-70. PubMed ID: 24805856
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Application of brush cytology for FISH-based detection of 1p/19q codeletion in oligodendroglial tumors.
    Srebotnik-Kirbiš I; Limbäck-Stokin C
    J Neurooncol; 2016 Sep; 129(3):415-422. PubMed ID: 27406587
    [TBL] [Abstract][Full Text] [Related]  

  • 25. ATRX immunohistochemistry can help refine 'not elsewhere classified' categorisation for grade II/III gliomas.
    Burford C; Laxton R; Sidhu Z; Aizpurua M; King A; Bodi I; Ashkan K; Al-Sarraj S
    Br J Neurosurg; 2019 Oct; 33(5):536-540. PubMed ID: 31018710
    [No Abstract]   [Full Text] [Related]  

  • 26. Radiological characteristics based on isocitrate dehydrogenase mutations and 1p/19q codeletion in grade II and III gliomas.
    Yamauchi T; Ohno M; Matsushita Y; Takahashi M; Miyakita Y; Kitagawa Y; Kondo E; Tsushita N; Satomi K; Yoshida A; Ichimura K; Narita Y
    Brain Tumor Pathol; 2018 Jul; 35(3):148-158. PubMed ID: 29922974
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Perfusion and diffusion MRI signatures in histologic and genetic subtypes of WHO grade II-III diffuse gliomas.
    Leu K; Ott GA; Lai A; Nghiemphu PL; Pope WB; Yong WH; Liau LM; Cloughesy TF; Ellingson BM
    J Neurooncol; 2017 Aug; 134(1):177-188. PubMed ID: 28547590
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Ancillary FISH analysis for 1p and 19q status: preliminary observations in 287 gliomas and oligodendroglioma mimics.
    Perry A; Fuller CE; Banerjee R; Brat DJ; Scheithauer BW
    Front Biosci; 2003 Jan; 8():a1-9. PubMed ID: 12456321
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Histological spectrum of oligodendroglial tumors: Only a subset shows 1p/19q codeletion.
    Pai T; Epari S; Desai S; Wadile A; Gupta T; Goda JS; Moiyadi A; Shetty P; Kane S; Jalali R
    Neurol India; 2017; 65(1):113-120. PubMed ID: 28084254
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Rare occurrence of IDH2 mutation in adolescent oligodendroglioma with 1p/19q co-deletion: a case report.
    Rao S; Sivakoti S; Arivazhagan A; Santosh V
    Childs Nerv Syst; 2020 Dec; 36(12):3109-3113. PubMed ID: 32296936
    [TBL] [Abstract][Full Text] [Related]  

  • 31. MRI and CT Identify Isocitrate Dehydrogenase
    Patel SH; Batchala PP; Mrachek EKS; Lopes MS; Schiff D; Fadul CE; Patrie JT; Jain R; Druzgal TJ; Williams ES
    Radiology; 2020 Jan; 294(1):160-167. PubMed ID: 31714193
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Relationship between radiological characteristics and combined 1p and 19q deletion in World Health Organization grade III oligodendroglial tumours.
    Kim JW; Park CK; Park SH; Kim YH; Han JH; Kim CY; Sohn CH; Chang KH; Jung HW
    J Neurol Neurosurg Psychiatry; 2011 Feb; 82(2):224-7. PubMed ID: 20587495
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Nogo-A: a useful marker for the diagnosis of oligodendroglioma and for identifying 1p19q codeletion.
    Marucci G; Di Oto E; Farnedi A; Panzacchi R; Ligorio C; Foschini MP
    Hum Pathol; 2012 Mar; 43(3):374-80. PubMed ID: 21835431
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical significance of chromosome 1p/19q loss of heterozygosity and Sox17 expression in oligodendrogliomas.
    Li J; Miao N; Liu M; Cui W; Liu X; Li X; Shi X; Qing S; Ma Y; Zhang W; Biekemituofu H
    Int J Clin Exp Pathol; 2014; 7(12):8609-15. PubMed ID: 25674225
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Oligodendrogliomas: new insights from the genetics and perspectives.
    Alentorn A; Sanson M; Idbaih A
    Curr Opin Oncol; 2012 Nov; 24(6):687-93. PubMed ID: 22913971
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Molecular imaging of 1p/19q deletion in oligodendroglial tumours with 11C-methionine positron emission tomography.
    Iwadate Y; Shinozaki N; Matsutani T; Uchino Y; Saeki N
    J Neurol Neurosurg Psychiatry; 2016 Sep; 87(9):1016-21. PubMed ID: 26848169
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Absence of 1p/19q codeletion in oligodendroglioma-like areas of pilocytic astrocytomas.
    Frazer B; Kearney H; Cryan J; Beausang A; Brett F; Farrell MA; Buckley PG
    Clin Neuropathol; 2018; 37(4):182-185. PubMed ID: 29595124
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Chromosome 1p loss evaluation in anaplastic oligodendrogliomas.
    Idbaih A; Kouwenhoven M; Jeuken J; Carpentier C; Gorlia T; Kros JM; French P; Teepen JL; Delattre O; Delattre JY; van den Bent M; Hoang-Xuan K
    Neuropathology; 2008 Aug; 28(4):440-3. PubMed ID: 18312547
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prognostic significance of relative 1p/19q codeletion in oligodendroglial tumors.
    Chamberlain MC; Born D
    J Neurooncol; 2015 Nov; 125(2):249-51. PubMed ID: 26341371
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Diagnostic and prognostic roles of loss of CIC protein expression in oligodendroglial tumors].
    Liu CC; Zhang LY; Wang LM; Wang DD; Fu YJ; Cai YN; Lu DH; Piao YS
    Zhonghua Bing Li Xue Za Zhi; 2017 Oct; 46(10):679-683. PubMed ID: 29050068
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.